These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 856457)

  • 1. Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero.
    Poskanzer DC; Herbst AL
    Cancer; 1977 Apr; 39(4 Suppl):1892-5. PubMed ID: 856457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of the genital tract following stilbestrol exposure in utero.
    Kurman RJ
    Recent Results Cancer Res; 1979; 66():161-74. PubMed ID: 373028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.
    Scully RE; Robboy SJ; Herbst AL
    Ann Clin Lab Sci; 1974; 4(4):222-33. PubMed ID: 4460850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stilbestrol, adenosis, and adenocarcinoma.
    Ulfelder H
    Am J Obstet Gynecol; 1973 Nov; 117(6):794-800. PubMed ID: 4745178
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural history of vaginal adenosis in women exposed to diethylstilbestrol in utero.
    Ng AB; Reagan JW; Nadji M; Greening S
    J Reprod Med; 1977 Jan; 18(1):1-13. PubMed ID: 833795
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenatal diethylstilbestrol exposure and human genital tract abnormalities.
    Herbst AL; Scully RE; Robboy SJ
    Natl Cancer Inst Monogr; 1979 May; (51):25-35. PubMed ID: 481577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Am J Obstet Gynecol; 1973 Jun; 116(4):470-84. PubMed ID: 4709483
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Trans Pac Coast Obstet Gynecol Soc; 1972; 40():15-29. PubMed ID: 4668177
    [No Abstract]   [Full Text] [Related]  

  • 15. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.
    Kurman RJ
    West J Med; 1979 Dec; 131(6):526-32. PubMed ID: 545869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
    Herbst AL; Scully RE; Robboy SJ
    J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenic and possible mutagenic effects of stilboestrol in offspring exposed in utero.
    Bishun NP; Smith NS; Williams DC; Raven RW
    J Surg Oncol; 1977; 9(3):293-300. PubMed ID: 327159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    J Med Assoc State Ala; 1977 Mar; 46(9):39-41. PubMed ID: 845523
    [No Abstract]   [Full Text] [Related]  

  • 19. Stilbestrol-adenosis-carcinoma syndrome: geographic distribution.
    Ulfelder H; Poskanzer D; Herbst AL
    N Engl J Med; 1971 Sep; 285(12):691. PubMed ID: 5563489
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
    Herbst AL
    Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.